Table 3.
Baseline characteristics and univariate analysis.
| Global (n = 185) | Control group (n = 79) | Incisional analgesia group (n = 106) | p | |
|---|---|---|---|---|
| Age (months) | 48 (13-83.50) | 24 (8-60) | 63 (35-98.25) | 0.001 |
| Gender: male (n, %) | 107 (57.8%) | 48 (60.8%) | 59 (55.7%) | 0.548 |
| RACHS1 score | 2 (1-4) | 2 (2-3) | 3 (2-3) | 0.033 |
| Extubation in the OR (n, %) | 131 (70.8%) | 42 (53.2%) | 89 (84%) | 0.001 |
| Intravenous fentanyl n (%) | 130 (70.3%) | 71 (89.9%) | 59 (57.3%) | 0.001 |
| Days of intravenous fentanyl | 2 (1-3) | 2 (1-3) | 1.5 (1-2) | 0.001 |
| Fentanyl dose (mcg/kg/h) | 1 (0.5-2) | 1 (1-2) | 1 (0.5-1.5) | 0.001 |
| Intravenous midazolam n (%) | 51 (27.6%) | 32 (40.5%) | 19 (17.9%) | 0.001 |
| Midazolam dose (mcg/kg/min) | 2 (1-2) | 2 (1-2) | 1.5 (1-2) | 0.001 |
| Intravenous propofol n (%) | 30 (16.2%) | 18 (22.8%) | 12 (11.3%) | 0.044 |
| Propofol dose (mg/kg/h) | 1.5 (1-2) | 1.5 (1-2) | 1.5 (1-2) | 0.065 |
| Days of intravenous metamizol | 3 (2-5) | 3 (2-4) | 4 (2-6) | 0.001 |
| COMFORT scale | 20.1 (18.7-22.3) | 19.2 (18-21.5) | 21.8 (20-23.5) | 0.001 |
| ANALGESIA scale | 1.7 (1-2.6) | 1.5 (0.97-2.77) | 2 (1-2.5) | 0.805 |
| Mechanical ventilation (hours) | 15.50 (6-24) | 12 (6-24) | 24 (3-36) | 0.198 |
| PICU LOS (days) | 4 (3-6) | 4 (3-4) | 5 (3-8) | 0.002 |
Cualitative variables are expressed in numbers and rates. Cuantitative variables are expressed in medians and interquartile ranges. Significant differences in italic characters. n: number of patients.